LTP — Ltr Pharma Cashflow Statement
0.000.00%
- AU$92.30m
- AU$60.49m
- AU$2.10m
- 54
- 30
- 20
- 26
Annual cashflow statement for Ltr Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0 | 0 | 0 | -0 | 1.96 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.029 | -0.568 | -1.54 | -5.09 | -4.44 |
| Capital Expenditures | — | — | -0.002 | -0.002 | -0.013 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -0.182 |
| Acquisition of Business | |||||
| Cash from Investing Activities | — | — | -0.002 | -0.002 | -0.195 |
| Financing Cash Flow Items | — | — | -0.069 | -0.504 | -2.13 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.178 | 2.34 | 1.38 | 6.5 | 33.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.146 | 1.76 | -0.183 | 1.37 | 28.7 |